康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09926 康方生物

未开盘 01-08 16:08:09

128.200

-1.000

-0.77%

最高130.500	最低127.000	成交量484.14万
今开130.400	昨收129.200	日振幅2.71%
总市值1,181亿	流通市值1,181亿	总股本9.21亿
成交额6.22亿	换手率0.53%	流通股本9.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":128.2,"timestamp":1767859689009,"preClose":129.2,"halted":0,"volume":4841419,"delay":0,"floatShares":921000000,"shares":921000000,"eps":-0.6746690184980286,"marketStatus":"未开盘","change":-1,"latestTime":"01-08 16:08:09","open":130.4,"high":130.5,"low":127,"amount":621907682,"amplitude":0.02709,"askPrice":128.3,"askSize":14000,"bidPrice":128.2,"bidSize":23000,"shortable":3,"etf":0,"ttmEps":-1.0786953058330346,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767922200000},"marketStatusCode":0,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":129.2,"openAndCloseTimeList":[[1767835800000,1767844800000],[1767848400000,1767859200000]],"volumeRatio":0.7620455987368182,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09926","defaultTab":"news","newsList":[{"id":"2602318472","title":"康方生物01月08日主力净流出522.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318472","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602318472?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:16","pubTimestamp":1767860162,"startTime":"0","endTime":"0","summary":"01月08日, 康方生物股价跌0.77%，报收128.20元，成交金额6.2亿元，换手率0.53%，振幅2.71%，量比0.76。康方生物今日主力资金净流出522.5万元，上一交易日主力净流入1.2亿元。该股近5个交易日上涨12.39%，主力资金累计净流入1.6亿元；近20日主力资金累计净流入1.0亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162840a7022a90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162840a7022a90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348827113.USD","LU0348767384.USD","LU1961090484.USD","LU0561508036.HKD","LU2476274308.USD","LU1794554557.SGD","LU2399975544.HKD","BK1161","IE00B5MMRT66.SGD","BK1574","09926","IE00B543WZ88.USD","LU0540923850.HKD","LU0348784397.USD","LU0417516738.SGD","LU0348783233.USD","LU0417516902.SGD","LU2488822045.USD","LU0348766576.USD","IE00BPRC5H50.USD","LU2778985437.USD","LU2476274720.SGD","LU1720050803.USD","LU0634319403.HKD","LU0348825331.USD","LU0417516571.SGD","LU0348735423.USD"],"gpt_icon":0},{"id":"2602318256","title":"万联证券：国内药企崭露头角 前沿平台与出海潜力成投资主脉","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318256","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602318256?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:26","pubTimestamp":1767842814,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，万联证券发布研报称，2025 年FDA 批准新药的创新“质量”提升和技术平台多元化，国内药企崭露头角。万联证券主要观点如下：事件2025 年，FDA 药品评价与研究中心共批准了46 款新药，虽然获批数量相较于2024 年及2023 年均有所下降，但是获批新药的类型丰富且创新性较高。国内药企中山康方生物医药有限公司的派安普利单抗和迪哲（江苏）医药股份有限公司的舒沃替尼获得FDA 批准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108115310a7014452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108115310a7014452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274308.USD","LU0348767384.USD","LU1794554557.SGD","LU0348825331.USD","LU0348784397.USD","IE00B543WZ88.USD","BK1161","LU0348827113.USD","IE00B5MMRT66.SGD","09926","LU1961090484.USD","LU0348735423.USD","LU0417516738.SGD","LU2476274720.SGD","LU0561508036.HKD","LU0348783233.USD","LU2399975544.HKD","LU2778985437.USD","LU0540923850.HKD","LU0634319403.HKD","IE00BPRC5H50.USD","LU0348766576.USD","LU0417516902.SGD","BK1574","LU1720050803.USD","LU2488822045.USD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2601808383","title":"港股概念追踪|国家药监局优化临床急需境外已上市药品审评审批    创新药高景气度延续（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2601808383","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601808383?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:07","pubTimestamp":1767830855,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，记者从国家药监局获悉，为加快临床急需境外已上市药品在境内上市，满足患者临床用药迫切需求，国家药监局进一步优化这类药品审评审批。公告显示，国家药监局将优化审评机制，加快审评速度;同时，也将完善检验制度，体现品种特点。据了解，2025年国家药监局批准上市的76个创新药，包括47个化学药品、23个生物制品和6个中药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","LU1794554557.SGD","IE00BPRC5H50.USD","09926","00013","LU2399975544.HKD","LU1720050803.USD","BK1587","LU2488822045.USD","159992","LU0348783233.USD","LU2476274308.USD","LU0417516738.SGD","LU0540923850.HKD","IE00B543WZ88.USD","LU0417516902.SGD","LU0348735423.USD","LU0417516571.SGD","LU0348766576.USD","LU0348784397.USD","06978","LU0348767384.USD","LU2778985437.USD","LU0348825331.USD","BK1191","BK1574","BK1161","LU0348827113.USD","LU1961090484.USD","BK1588","LU0561508036.HKD","LU2476274720.SGD","LU0634319403.HKD"],"gpt_icon":0},{"id":"2601316386","title":"3500万美元到账后，宜明昂科超20亿美元BD合作终止，创始人田文志：美国临床推进缓慢","url":"https://stock-news.laohu8.com/highlight/detail?id=2601316386","media":"时代财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601316386?lang=zh_cn&edition=full","pubTime":"2026-01-07 19:19","pubTimestamp":1767784795,"startTime":"0","endTime":"0","summary":"宜明昂科为何与美国药企终止协议？此次终止不影响宜明昂科已从Axion收到的3500万美元首付款和里程碑付款。临床试验进展乏力成为此次合作终止的导火索。去年8月是宜明昂科最后一次收到BD交易款项，过往五次总计金额为3500万美元，这也是此次交易终止时不可退还的款项。随着BD款项陆续到账，双方的合作项目也在持续推进。但实际上，在2026年开年不到一周，宜明昂科与Instil Bio双方就终止了合作。据公开资料，其于2025年4月开始担任这一职位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107192006a6fe8396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107192006a6fe8396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516571.SGD","LU0348767384.USD","LU1720050803.USD","LU0348827113.USD","BK1161","LU0540923850.HKD","LU0561508036.HKD","LU0348783233.USD","LU2476274720.SGD","IE00B543WZ88.USD","LU2488822045.USD","01541","BK1574","TIL","IE00BPRC5H50.USD","LU0348735423.USD","LU2399975544.HKD","LU2476274308.USD","LU0634319403.HKD","IE00B5MMRT66.SGD","LU0417516738.SGD","LU0417516902.SGD","09926","LU2778985437.USD","LU0348766576.USD","LU0348784397.USD","LU1961090484.USD","LU0348825331.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2601386393","title":"每日卖空追踪 | 康方生物 01月07日卖空量成交49.4万股，卖空比例为4.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601386393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601386393?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774644,"startTime":"0","endTime":"0","summary":"康方生物北京时间01月07日，涨7.31%，卖空量成交49.4万股，较上一交易日减少40.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163646a4a6e979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163646a4a6e979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0348766576.USD","LU0540923850.HKD","09926","LU2476274308.USD","LU0417516738.SGD","LU0348827113.USD","LU0634319403.HKD","LU2488822045.USD","IE00B543WZ88.USD","LU0417516902.SGD","LU0348735423.USD","LU1720050803.USD","IE00BPRC5H50.USD","LU0561508036.HKD","LU0348825331.USD","LU0348784397.USD","BK1574","LU1794554557.SGD","LU0348783233.USD","LU2778985437.USD","LU2399975544.HKD","LU2476274720.SGD","LU0417516571.SGD","LU1961090484.USD","IE00B5MMRT66.SGD","LU0348767384.USD"],"gpt_icon":0},{"id":"2601760808","title":"港股创新药ETF基金涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601760808","media":"云掌财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601760808?lang=zh_cn&edition=full","pubTime":"2026-01-07 13:58","pubTimestamp":1767765495,"startTime":"0","endTime":"0","summary":"盘面上，港股创新药表现活跃，凯莱英飙涨7%，泰格医药、昭衍新药、康方生物涨超5%，和黄医药、翰森制药、恒瑞医药等个股涨超4%。截至10：34，热门ETF——港股创新药ETF基金上涨2.85%，冲击三连涨！数据显示，港股创新药ETF基金近60日“吸金”超1亿；最新基金规模达9.39亿元。港股创新药ETF基金跟踪中证港股通创新药指数，指数编制方式更科学合理，成分股涵盖如百济神州、信达生物和药明生物等领军企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06821","BK1191","02269","09926","01801","01276","02315","06127","00013","BK1574","03692","06978"],"gpt_icon":0},{"id":"2601825895","title":"罕见病创新药内地首张处方药开出 港股通创新药ETF板块迎双重驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2601825895","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601825895?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:27","pubTimestamp":1767756474,"startTime":"0","endTime":"0","summary":"近日，罕见病创新药司拉德帕在中国内地开出了首张处方。创新药物将走入更多寻常百姓家。1月7日，盘中港股创新药持续走强。港股通创新药ETF嘉实盘中涨超3%。2026年我国医药生物行业将正式步入创新药大时代，创新药将逐渐占据我国医药生物行业的主导地位，医保商保的互补结合将长期打开支付空间的天花板，创新药将持续蓬勃发展。创新药产业链行业，受益于创新药的快速发展预计仍将保持良好增长势头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107112826a6fcca5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107112826a6fcca5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09926","BK1141","03347","BK1161","02157","BK1576","01530","06978","BK1574"],"gpt_icon":0},{"id":"2601082346","title":"港股异动 | 康方生物(09926)再涨超6% 依沃西说明书重磅更新 纳入AK112-301研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2601082346","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601082346?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:23","pubTimestamp":1767756230,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康方生物再涨超6%，截至发稿，涨6.15%，报127.8港元，成交额7.89亿港元。消息面上，康方生物宣布，国家药品监督管理局已批准公司自主研发的全球首创PD-1/VEGF双特异性抗体依沃西说明书的一项重要更新：更新纳入了AK112-301/HARMONi-A研究的最终分析数据，即依沃西联合疗法治疗EGFR-TKI治疗后进展的局部晚期或转移性非鳞状非小细胞肺癌取得的具有统计学显著性和临床意义的无进展生存期和总生存期双重获益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0417516902.SGD","LU2488822045.USD","BK1574","IE00B5MMRT66.SGD","LU2778985437.USD","LU1961090484.USD","LU0540923850.HKD","BK1161","LU0348825331.USD","LU2399975544.HKD","IE00BPRC5H50.USD","09926","LU0634319403.HKD","LU0348735423.USD","LU0348783233.USD","LU0348784397.USD","LU0417516571.SGD","LU0561508036.HKD","LU0348767384.USD","LU2476274720.SGD","LU2476274308.USD","LU0348827113.USD","LU1720050803.USD","LU0417516738.SGD","LU0348766576.USD","LU1794554557.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1182469709","title":"康方生物科技（09926）2025年12月股份月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1182469709","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182469709?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:01","pubTimestamp":1767690073,"startTime":"0","endTime":"0","summary":"康方生物科技（开曼）有限公司于2026年1月6日发布2025年12月股份变动月报表。报告期内，公司法定股本与已发行股份数均未发生变化，股本维持稳定。截至2025年12月31日，已发行普通股总数为921,143,176股，较上月底无新增发行、购回或注销活动，库存股数量仍为零。鉴于本月内未有任何新增股份发行或回购，公司总体股本状况继续保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"gpt_icon":0},{"id":"2601868644","title":"中信建投：脑机接口有望打开万亿市场空间 需发掘国家政策支持和具有真实需求“真脑机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2601868644","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601868644?lang=zh_cn&edition=full","pubTime":"2026-01-06 11:27","pubTimestamp":1767670058,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，脑机接口升级为十五五产业战略，多重政策强力支持下，产业落地有望提速，建议重视投资机遇。脑机接口是医疗投资也是科技投资，短期来看主要应用于疾病治疗，长期来看若能实现增强人、并与AI和机器人融合，有望打开万亿市场空间。在投资方向选择方面，非侵入式和侵入式脑机接口无优劣之分，但需发掘国家政策支持和具有真实需求的“真脑机”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106113407a6f87063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106113407a6f87063&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","BK1574","BK1141","LU2242644610.SGD","01177","06160","BK1161","LU0708995583.HKD","02269","BK1583","LU0052750758.USD","09926","01099","SHPMY","00013","02359","02607","01801","BK1576","LU0320764599.SGD","06978","03347","LU1046422090.SGD","LU2045819591.USD"],"gpt_icon":0},{"id":"2601832208","title":"每日卖空追踪 | 康方生物 01月05日卖空量成交53.9万股，卖空比例为7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601832208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601832208?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601841,"startTime":"0","endTime":"0","summary":"康方生物北京时间01月05日，涨3.35%，卖空量成交53.9万股，较上一交易日增加43.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163842a6f52835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163842a6f52835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","LU0417516902.SGD","LU0348767384.USD","LU0417516571.SGD","LU0348766576.USD","LU2778985437.USD","LU0561508036.HKD","BK1574","LU2476274720.SGD","IE00BPRC5H50.USD","LU2399975544.HKD","LU1720050803.USD","LU0417516738.SGD","LU2476274308.USD","IE00B543WZ88.USD","LU0540923850.HKD","LU0348827113.USD","LU0348784397.USD","BK1161","LU2488822045.USD","LU0348735423.USD","LU1961090484.USD","IE00B5MMRT66.SGD","LU1794554557.SGD","LU0348825331.USD","09926","LU0634319403.HKD"],"gpt_icon":0},{"id":"2601183224","title":"康方生物01月05日获主力加仓1726.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601183224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601183224?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600956,"startTime":"0","endTime":"0","summary":"01月05日, 康方生物股价涨3.35%，报收117.10元，成交金额8.6亿元，换手率0.80%，振幅6.44%，量比1.76。康方生物今日主力资金净流入1726.1万元，上一交易日主力净流入325.1万元。该股近5个交易日上涨4.09%，主力资金累计净流出3544.4万元；近20日主力资金累计净流出3848.4万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162214a6f51457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162214a6f51457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348735423.USD","LU2476274720.SGD","LU1961090484.USD","LU0348766576.USD","LU0540923850.HKD","LU2778985437.USD","LU0634319403.HKD","LU0417516902.SGD","LU0348784397.USD","LU0561508036.HKD","LU2399975544.HKD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348825331.USD","BK1574","LU0348783233.USD","LU0417516738.SGD","09926","LU0417516571.SGD","LU2488822045.USD","LU1720050803.USD","LU2476274308.USD","LU0348827113.USD","IE00B5MMRT66.SGD","BK1161","LU0348767384.USD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2601029158","title":"恒瑞、百济双雄挺进TOP20！翰森、博泰加速冲刺，11家中国药企入榜，药企市值TOP50大洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029158","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601029158?lang=zh_cn&edition=full","pubTime":"2026-01-04 21:09","pubTimestamp":1767532195,"startTime":"0","endTime":"0","summary":"2025年的全球药企市值TOP50榜单，不再是跨国巨头的独角戏，11家中国药企集体亮剑。从“还差临门一脚”到稳坐TOP20一隅如果将时间拨回到2023年，中国药企在全球市值TOP50中的处境，常被形容为还差“临门一脚”。而到了2025年末，中国药企在全球药企市值的排行已经发生了实质性改变。恒瑞在2025年中登陆港交所后，其在港股市值一度突破5000亿港元。首次冲进全球制药企业市值TOP20的百济，则代表着另一条路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104212120a6f20aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104212120a6f20aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1161","BK1583","09926","01801","06990","03692","BK1191","06160","LU0196878994.USD"],"gpt_icon":0},{"id":"2595877900","title":"中山全市研发经费投入连续三年超百亿，康方生物7个新药已上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2595877900","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595877900?lang=zh_cn&edition=full","pubTime":"2025-12-31 20:36","pubTimestamp":1767184601,"startTime":"0","endTime":"0","summary":"南方财经21世纪经济报道记者郑全怡广州报道12月31日，“十四五”广东成就系列新闻发布会中山专场在广州召开，详细介绍了“十四五”时期中山市经济社会发展的总体情况和主要成就。“十四五”期间，中山地区生产总值连续跨越3500亿、4000亿元关口，预计2025年将突破4200亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512313607147856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512313607147856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0348825331.USD","LU0634319403.HKD","LU1720050803.USD","LU0348827113.USD","LU2476274308.USD","LU0540923850.HKD","09926","BK1161","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU1961090484.USD","LU0417516738.SGD","LU0348783233.USD","LU2399975544.HKD","LU0561508036.HKD","LU0417516902.SGD","LU0417516571.SGD","LU0348735423.USD","LU0348766576.USD","LU2778985437.USD","LU0348767384.USD","LU1794554557.SGD","LU2476274720.SGD","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"2595493207","title":"每日卖空追踪 | 康方生物 12月30日卖空量成交31.6万股，卖空比例为5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595493207","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595493207?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083441,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月30日，跌0.27%，卖空量成交31.6万股，较上一交易日减少34.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163659a6e08047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163659a6e08047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516738.SGD","LU0348767384.USD","LU0561508036.HKD","LU1961090484.USD","LU0348825331.USD","LU1794554557.SGD","LU2778985437.USD","LU2399975544.HKD","LU0348784397.USD","09926","LU2488822045.USD","BK1574","LU0348735423.USD","LU0348766576.USD","BK1161","IE00B5MMRT66.SGD","LU0634319403.HKD","LU0417516902.SGD","LU2476274308.USD","LU0417516571.SGD","IE00B543WZ88.USD","LU0540923850.HKD","LU0348827113.USD","LU2476274720.SGD","IE00BPRC5H50.USD","LU0348783233.USD","LU1720050803.USD"],"gpt_icon":0},{"id":"2595009734","title":"每日卖空追踪 | 康方生物 12月29日卖空量成交24.9万股，卖空比例为4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595009734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595009734?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997040,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月29日，跌0.89%，卖空量成交24.9万股，较上一交易日增加72.92%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163707a4854d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163707a4854d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516571.SGD","IE00B5MMRT66.SGD","LU1720050803.USD","LU2778985437.USD","LU0417516902.SGD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU2488822045.USD","LU0348766576.USD","LU0540923850.HKD","BK1574","LU0634319403.HKD","LU2476274720.SGD","LU0561508036.HKD","BK1161","LU0417516738.SGD","LU2476274308.USD","LU0348767384.USD","LU0348825331.USD","LU2399975544.HKD","09926","LU0348783233.USD","LU0348827113.USD","IE00BPRC5H50.USD","LU1961090484.USD","LU0348735423.USD"],"gpt_icon":0},{"id":"2595973288","title":"华海药业HB0025注射液Ⅲ期临床启动，3亿研发加码多靶点抗癌药领域！","url":"https://stock-news.laohu8.com/highlight/detail?id=2595973288","media":"摩熵医药大数据","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595973288?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:01","pubTimestamp":1766991697,"startTime":"0","endTime":"0","summary":"12月26日，据$华海药业发布公告，其下属子公司上海华奥泰生物的 HB0025 联合化疗一线治疗鳞状和非鳞状非小细胞肺癌经过与国家药品监督管理局药品审评中心Ⅱ期临床试验结束/Ⅲ期临床试验启动前的会议沟通，公司将正式启动 HB0025注射液 的III期临床试验。根据和CDE的会议沟通，华海药业将启动两项确证性III期临床试验。截至目前，华海药业已在 HB0025 项目上已合计投入研发费用约人民币32,597万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229152223a6dc0065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229152223a6dc0065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0634319403.HKD","LU0348766576.USD","LU2476274308.USD","LU0561508036.HKD","LU0348827113.USD","BK1161","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1961090484.USD","LU0348767384.USD","LU2476274720.SGD","09926","LU2488822045.USD","LU2778985437.USD","LU0417516902.SGD","LU2399975544.HKD","IE00B543WZ88.USD","LU1720050803.USD","LU0348783233.USD","LU1794554557.SGD","BK1574","LU0540923850.HKD","LU0417516738.SGD","LU0348784397.USD","LU0348825331.USD","LU0348735423.USD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2595673500","title":"国产银屑病创新药密集突破！正大天晴重磅1类新药2期临床取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673500","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595673500?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:00","pubTimestamp":1766991624,"startTime":"0","endTime":"0","summary":"如中国生物制药于12月29日宣布，正大天晴自主研发的1类创新药TQH3906用于中重度斑块状银屑病的二期临床试验，达到主要研究终点。除了在研药物的稳步推进，国内还有多款治疗中重度斑块状银屑病的创新药已经获批上市。国产银屑病创新药的密集突破，不仅打破了此前临床治疗对进口药物的依赖，更推动我国银屑病治疗进入精准靶向的新时代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229150230a6dbeecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229150230a6dbeecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1161","BK1574","LU0359201885.HKD","LU2543165471.USD","LU1023057109.AUD","09926","01276","BK1191","LU0359201612.USD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2593477930","title":"国内商保发展和集采优化 创新药产业链持续活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477930","media":"金证研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477930?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:11","pubTimestamp":1766581900,"startTime":"0","endTime":"0","summary":"随着国内商保发展和集采优化，创新药产业链高景气有望延续。当前支持创新药产业发展已成为政策导向，2025年北京、上海、重庆、四川等多地出台相关政策，推动创新药行业高质量发展。近日，2026年医保药品目录和商保药品目录发布，首次在基本医保目录之外增设商保创新药目录。创新药长期产业趋势确定，在国内政策支持以及美联储进入降息周期的背景下，全球创新药研发持续活跃，2026年还有大量BD落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224211713a6ca8bf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224211713a6ca8bf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","ONC","LU0417516738.SGD","LU1720050803.USD","LU0348825331.USD","LU2476274308.USD","IE00BPRC5H50.USD","BK1161","LU0417516902.SGD","LU1794554557.SGD","LU2399975544.HKD","09926","LU2778985437.USD","IE00B5MMRT66.SGD","LU0348827113.USD","LU0417516571.SGD","LU0348767384.USD","06978","LU0634319403.HKD","LU0348783233.USD","01801","LU0348784397.USD","01877","LU0348735423.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348766576.USD","01276","LU2476274720.SGD","LU0561508036.HKD","BK1574","LU1961090484.USD"],"gpt_icon":0},{"id":"2593477672","title":"每日卖空追踪 | 康方生物 12月24日卖空量成交14.4万股，卖空比例为7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477672?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565039,"startTime":"0","endTime":"0","summary":"康方生物北京时间12月24日，跌0.62%，卖空量成交14.4万股，较上一交易日减少69.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163649a4728327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163649a4728327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","LU0348766576.USD","LU0348767384.USD","LU2476274308.USD","LU2488822045.USD","BK1574","LU0348827113.USD","LU0417516571.SGD","LU0634319403.HKD","LU0417516902.SGD","LU2399975544.HKD","BK1161","LU2476274720.SGD","LU0540923850.HKD","LU0348825331.USD","LU1794554557.SGD","LU2778985437.USD","IE00B543WZ88.USD","LU0348735423.USD","LU0417516738.SGD","LU0348783233.USD","LU1961090484.USD","LU1720050803.USD","LU0348784397.USD","09926","IE00BPRC5H50.USD","LU0561508036.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akesobio.com","stockEarnings":[{"period":"1week","weight":0.1345},{"period":"1month","weight":0.0737},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1325},{"period":"1year","weight":1.2811},{"period":"ytd","weight":0.1345}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0281},{"period":"3month","weight":-0.0054},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.3563},{"period":"ytd","weight":0.0202}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康方生物科技（开曼）有限公司是一家致力于研究、开发、生产及商业化让全球病人可负担的抗体药的投资控股公司。该公司在研项目涵盖肿瘤、自身免疫及代谢性疾病等多个领域。该公司的产品主要包括有用于肿瘤领域的开坦尼（卡度尼利，PD-1/CTLA-4）、依达方（依沃西，PD-1/VEGF）、莱法利（AK117，CD47）、普络西（AK109，VEGFR-2）、安尼可（派安普利，PD-1）、科泰莱（塔戈利单抗，PD-L1）和用于代谢及自免领域的伊喜宁（伊努西单抗，PCSK9）、爱达罗（依若奇单抗，IL-12/IL-23）、古莫奇单抗（AK111，IL-17）。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022915},{"month":2,"riseRate":0.4,"avgChangeRate":0.029178},{"month":3,"riseRate":0.4,"avgChangeRate":-0.035342},{"month":4,"riseRate":0.8,"avgChangeRate":0.041218},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.003133},{"month":6,"riseRate":0.666667,"avgChangeRate":0.133235},{"month":7,"riseRate":0.5,"avgChangeRate":0.087867},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007754},{"month":9,"riseRate":0.5,"avgChangeRate":0.036209},{"month":10,"riseRate":0.5,"avgChangeRate":0.046029},{"month":11,"riseRate":1,"avgChangeRate":0.102206},{"month":12,"riseRate":0.333333,"avgChangeRate":0.028279}],"exchange":"SEHK","name":"康方生物","nameEN":"AKESO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康方生物,09926,康方生物股票,康方生物股票老虎,康方生物股票老虎国际,康方生物行情,康方生物股票行情,康方生物股价,康方生物股市,康方生物股票价格,康方生物股票交易,康方生物股票购买,康方生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}